Bronchiolitis obliterans after hematopoietic stem cell transplantation

A. Roca Noval; M. Erro; M. Hernández; C. Acosta; L. Diab; R. M. Girón

Bronchiolitis obliterans after hematopoietic stem cell transplantation

A. Roca Noval, M. Erro, M. Hernández, C. Acosta, L. Diab, R. M. Girón

Producció científica: Article en revista indexada › Article › Avaluat per experts

Resum

Hematopoietic stem cell transplantation is an established treatment with a high curative potential for various hematological diseases. Chronic graft-versus-host disease is a major complication of this procedure and is the leading cause of late mortality after transplantation. Bronchiolitis obliterans is a particularly serious complication that occurs in 10-15% of patients with extensive graft-versus-host disease and is often refractory to treatment. If there is no response to conventional immunosuppressive treatment after 3-6 months of treatment, the prognosis of these patients is unfortunate. We report the case of a 57 year old woman diagnosed with a chronic T lymphoproliferative syndrome who developed bronchiolitis obliterans one year after an hematopoietic stem cell transplantation.

Títol traduït de la contribució	Bronquiolitis obliterante tras trasplante de progenitores hematopoyéticos
Idioma original	Anglès
Pàgines (de-a)	97-100
Nombre de pàgines	4
Revista	Revista de Patologia Respiratoria
Volum	20
Número	3
Estat de la publicació	Publicada - 1 de jul. 2017
Publicat externament	Sí

Altres arxius i enllaços

Enllaç a la publicació de Scopus

Com citar-ho

@article{e7024ea6973346f58afa524726643863,

title = "Bronchiolitis obliterans after hematopoietic stem cell transplantation",

abstract = "Hematopoietic stem cell transplantation is an established treatment with a high curative potential for various hematological diseases. Chronic graft-versus-host disease is a major complication of this procedure and is the leading cause of late mortality after transplantation. Bronchiolitis obliterans is a particularly serious complication that occurs in 10-15% of patients with extensive graft-versus-host disease and is often refractory to treatment. If there is no response to conventional immunosuppressive treatment after 3-6 months of treatment, the prognosis of these patients is unfortunate. We report the case of a 57 year old woman diagnosed with a chronic T lymphoproliferative syndrome who developed bronchiolitis obliterans one year after an hematopoietic stem cell transplantation.",

keywords = "Bronchiolitis obliterans, Chronic graft-versus-host disease, Hematopoietic stem cell transplantation",

author = "{Roca Noval}, A. and M. Erro and M. Hern{\'a}ndez and C. Acosta and L. Diab and Gir{\'o}n, {R. M.}",

note = "Funding Information: 5. Jagasia MH, Greinix TH, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria For Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Stanging Working Group Report. Biol Blood Marrow Transplant. 2015; 21: 389-401.",

year = "2017",

month = jul,

day = "1",

language = "English",

volume = "20",

pages = "97--100",

journal = "Revista de Patologia Respiratoria",

issn = "1576-9895",

publisher = "Fundacion Neumomadrid",

number = "3",

}

TY - JOUR

T1 - Bronchiolitis obliterans after hematopoietic stem cell transplantation

AU - Roca Noval, A.

AU - Erro, M.

AU - Hernández, M.

AU - Acosta, C.

AU - Diab, L.

AU - Girón, R. M.

N1 - Funding Information: 5. Jagasia MH, Greinix TH, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria For Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Stanging Working Group Report. Biol Blood Marrow Transplant. 2015; 21: 389-401.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Hematopoietic stem cell transplantation is an established treatment with a high curative potential for various hematological diseases. Chronic graft-versus-host disease is a major complication of this procedure and is the leading cause of late mortality after transplantation. Bronchiolitis obliterans is a particularly serious complication that occurs in 10-15% of patients with extensive graft-versus-host disease and is often refractory to treatment. If there is no response to conventional immunosuppressive treatment after 3-6 months of treatment, the prognosis of these patients is unfortunate. We report the case of a 57 year old woman diagnosed with a chronic T lymphoproliferative syndrome who developed bronchiolitis obliterans one year after an hematopoietic stem cell transplantation.

AB - Hematopoietic stem cell transplantation is an established treatment with a high curative potential for various hematological diseases. Chronic graft-versus-host disease is a major complication of this procedure and is the leading cause of late mortality after transplantation. Bronchiolitis obliterans is a particularly serious complication that occurs in 10-15% of patients with extensive graft-versus-host disease and is often refractory to treatment. If there is no response to conventional immunosuppressive treatment after 3-6 months of treatment, the prognosis of these patients is unfortunate. We report the case of a 57 year old woman diagnosed with a chronic T lymphoproliferative syndrome who developed bronchiolitis obliterans one year after an hematopoietic stem cell transplantation.

KW - Bronchiolitis obliterans

KW - Chronic graft-versus-host disease

KW - Hematopoietic stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=85031760352&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85031760352

SN - 1576-9895

VL - 20

SP - 97

EP - 100

JO - Revista de Patologia Respiratoria

JF - Revista de Patologia Respiratoria

IS - 3

ER -

Bronchiolitis obliterans after hematopoietic stem cell transplantation

Resum

Altres arxius i enllaços

Fingerprint

Com citar-ho